Merus reports 1.51M shares (5.3%) in Bleichroeder II
Bleichroeder Acquisition Corp. II Schedule 13G shows Merus Global Investments, LLC beneficially owns 1,510,876 shares of the issuer's Class A ordinary shares, representing 5.3% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bleichroeder Acquisition Corp. II Schedule 13G shows Merus Global Investments, LLC beneficially owns 1,510,876 shares of the issuer's Class A ordinary shares, representing 5.3% of the class. The filing ties that percentage to May 26, 2026, based on 28,750,000 shares outstanding reported in the issuer's Form F-4. The filing lists sole voting and sole dispositive power over the 1,510,876 shares and is signed by the filer’s General Counsel.
Insights
Merus reports a 5.3% passive stake with sole voting and dispositive power.
Merus Global Investments, LLC reports beneficial ownership of 1,510,876 shares, equal to 5.3% of the Class A ordinary shares, calculated from the issuer's stated 28,750,000 shares outstanding as of May 26, 2026. The filing is a standard Schedule 13G disclosure of position size and voting/dispositive authority.
Cash-flow treatment and intentions regarding holdings are not stated in the excerpt; subsequent filings would show any change in status or intent.
Filing documents sole voting/dispositive authority — governance relevance only.
The Schedule 13G explicitly shows Merus holds sole voting and sole dispositive power over the reported 1,510,876 shares. That indicates control over voting direction for this position but does not by itself indicate change in control or transaction activity.
Watch for future amendments that convert to a Schedule 13D or disclose acquisitions, dispositions, or arrangements affecting control.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially owned financial
sole dispositive power corporate governance
Form F-4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Merus Global Investments report in BBCQ?
What date is used to calculate the 5.3% ownership in the filing?
Who signed the Schedule 13G for Merus Global Investments?
Does this Schedule 13G disclose Merus’s intent to influence Bleichroeder Acquisition Corp. II?
AI-generated analysis. How Rhea-AI works. Not financial advice.